CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis is a devastating fibrotic diffuse parenchymal lung disorder that remains refractory to pharmacological therapies. Therefore, novel treatments are urgently required. CCAAT/enhancer binding protein delta (C/EBPδ) is a transcription factor that mediates critica...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Transl Res
Autors principals: JanWillem, Duitman, Lin, Cong, Moog, Sophie, Jaillet, Madeleine, Castier, Yves, Cazes, Aurélie, Borensztajn, Keren S., Crestani, Bruno, Spek, C. Arnold
Format: Artigo
Idioma:Inglês
Publicat: Whioce Publishing Pte. Ltd. 2018
Matèries:
Special Issue Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6412614/
https://ncbi.nlm.nih.gov/pubmed/30873483
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars